NCT ID | NCT03432741 |
Title | Direct Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast Cancer |
Recruitment | Recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | no |
Sponsors | Mayo Clinic |
Indications | |
Therapies | |
Age Groups: | adult senior |